Research Areas
In ths section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 2937 | ZT-12-037-01 | Specific STK19 inhibitor | €95.00 | |
| 2385 | WZ 4003 | Specific dual inhibitor of NUAK1 (ARK5) and NUAK2 (SNARK) | €80.00 | |
| 3068 | WEHI-9625 | First-in-class, potent, and selective mBAK-mediated apoptosis inhibitor | €150.00 | |
| 2628 | TMS | CYP1B1 inhibitor that induces apoptosis in human cancer cells | €75.00 | |
| 1564 | Tienilic Acid | CYP2C10 Inhibitor | €75.00 | |
| 1960 | Tariquidar | Inhibitor of P-glycoprotein (P-gp, ABCB1) | €135.00 | |
| 2124 | TAK 700 | Potent and highly selective inhibitor of 17,20-lyase (CYP17A1) | €105.00 | |
| 2922 | Sulfaphenazole | CYP2C9 inhibitor; Antibiotic | €60.00 | |
| 1136 | SU 6656 | SRC kinase inhibitor | €120.00 | |
| 2743 | STK16-IN-1 | ATP-competitive STK16 inhibitor | €125.00 | |
| 1865 | Stemregenin 1 | Aryl hydrocarbon receptor (AHR) antagonist | €105.00 | |
| 2778 | Squarunkin A | Selective UNC119–cargo interaction inhibitor | €125.00 | |
| 2627 | SMER 28 | Small molecule enhancer of rapamycin that enhances autophagy | €80.00 | |
| 1701 | Shz-1 | Stem cell differentiating agent; Nkx2.5 inducer | €95.00 | |
| 3284 | Saracatinib | Inhibitor of SRC and ABL tyrosine kinases | €70.00 | |